RESUMEN
The effect of two dose-schedules of Pirenzepine (25 mg b.d. or 50 mg t.d.s. during 2 1/2 days) on histamine-stimulated gastric acid secretion was tested in eleven healthy volunteers. Gastric secretory responses were calculated as acid output values and as VG-values (VG = gastric secretory volume corrected for duodeno-gastric reflux and pyloric loss). Stimulated acid output per two hours was reduced with Pirenzepine 25 mg b.d. by 12.5% (n.s.), with Pirenzepine 50 mg t.d.s. by 21% (p less than 0.01). Stimulated VG per two hours was reduced with Pirenzepine 25 mg b.d. by 15.8% (p less than 0.01) and with Pirenzepine 50 mg t.d.s. by 24% (p less than 0.01). Pirenzepine reduces histamine-stimulated gastric acid output to a similar degree as other anticholinergic drugs. Reduction seems to be due to true inhibition of acid secretion and not to altered gastric motility.
Asunto(s)
Benzodiazepinonas/farmacología , Ácido Gástrico/metabolismo , Histamina/farmacología , Adolescente , Adulto , Relación Dosis-Respuesta a Droga , Femenino , Humanos , Masculino , Persona de Mediana Edad , Pirenzepina , Estimulación QuímicaRESUMEN
A six week course of cimetidine (1 g/day) healed peptic ulcers in 20 of 23 patients (14 with duodenal ulcer, nine with gastric ulcer). Reduction of basal acid output by 73% and peak acid output by 36% led to a rise in concentrations of intragastric aerobic bacteria and nitrate-reducing bacteria. While the mean intragastric concentration of nitrate was unchanged by treatment, there were statistically significant rises in nitrite and N-nitrosamine concentrations. The conversion from nitrates to nitrites was closely related to the occurrence of nitrate-reducing bacteria. In three patients the intragastric milieu had returned to normal two months after cimetidine treatment had been discontinued. Mean nitrite and N-nitrosamine concentrations did not return to pre-treatment levels in the group of eight patients who remained on maintenance cimetidine (0.4 g at night-time) for three months after the full dose treatment. This study shows that cimetidine treatment can create an intragastric milieu resembling that of atrophic gastritis. Large scale and long-term studies are necessary to establish whether these findings have any clinical significance.